GGrantIndex
Sort

53,477 grants matching addiction

NOVEL COCAINE PHARMACOTHERAPIES: LAB STUDIES

$503,020
Columbia University Health Sciences · R01 · FY2001 · DA

Opioid Patients: Behavioral Family Counseling and Naltrexone

$503,020
Timothy James O'Farrell · Harvard Medical School · R01 · FY2010 · DA

Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction

$502,990
Richard De La Garza · Baylor College Of Medicine · R01 · FY2009 · DA

SELECTIVE NONPEPTIDE OPIOID LIGANDS

$502,959
University Of Minnesota Twin Cities · R37 · FY2004 · DA

tDCS to Decrease Opioid Relapse

$502,784
Ana M Abrantes · Butler Hospital (Providence, Ri) · UH3 · FY2024 · DA

Training Program: Drugs of Abuse & Related Neuropeptides

$502,754
Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2017 · DA

Parent-Child Interaction Dynamics Mediate Genetic and Prevention Effects on the Development of Adolescent Substance Use Disorders

$502,752
Jenn-Yun Tein · Arizona State University-Tempe Campus · R01 · FY2022 · DA

CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr

$502,744
T John Winhusen · University Of Cincinnati · UG1 · FY2024 · DA

Plasticity and Function of Dopamine Circuits Regulating the Transition to Habit

$502,708
Talia Newcombe Lerner · Northwestern University At Chicago · R01 · FY2025 · MH

Plasticity and Function of Dopamine Circuits Regulating the Transition to Habit

$502,708
Talia Newcombe Lerner · Northwestern University At Chicago · R01 · FY2024 · MH

Plasticity and Function of Dopamine Circuits Regulating the Transition to Habit

$502,708
Talia Newcombe Lerner · Northwestern University At Chicago · R01 · FY2023 · MH

Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake

$502,688
Sven-Eric Jordt · Duke University · R01 · FY2018 · ES

Cognitive control and cocaine dependence: thalamic noradrenergic processes

$502,664
Chiang-Shan Ray Li · Yale University · R01 · FY2015 · DA

Vital Signs In Opioid-Exposed Neonates

$502,655
Namasivayam Ambalavanan · University Of Alabama At Birmingham · R01 · FY2024 · HD

Varieties of Impulsivity in Opiate and Stimulant Users

$502,614
Jasmin L Vassileva · Virginia Commonwealth University · R01 · FY2023 · DA

Extracellular vesicles in semen and genital HIV infection and immunity during heroin addiction and methadone or buprenorphine substitution therapy

$502,606
Florian Hladik · University Of Washington · R01 · FY2019 · DA

Targeted Inhibition in Leukemia

$502,537
Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA

Deciphering the single-nucleus genomic regulatory structure of opioid use disorder in the human brain

$502,500
Janitza Liz Montalvo-Ortiz · Yale University · DP1 · FY2024 · DA

SBIRT for Substance Abuse in Mental Health Treatment Settings

$502,500
Mitchell P Karno · University Of California Los Angeles · R01 · FY2012 · DA

Deciphering the single-nucleus genomic regulatory structure of opioid use disorder in the human brain

$502,500
Janitza Liz Montalvo-Ortiz · Yale University · DP1 · FY2025 · DA

Deciphering the single-nucleus genomic regulatory structure of opioid use disorder in the human brain

$502,500
Janitza Liz Montalvo-Ortiz · Yale University · DP1 · FY2023 · DA

Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the amygdala

$502,483
Edita Navratilova · University Of Arizona · R01 · FY2021 · NS

Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the amygdala

$502,483
Edita Navratilova · University Of Arizona · R01 · FY2023 · NS

Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the amygdala

$502,483
Edita Navratilova · University Of Arizona · R01 · FY2020 · NS

Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the amygdala

$502,483
Edita Navratilova · University Of Arizona · R01 · FY2022 · NS